Home / Managers get another battering about fees

Managers get another battering about fees

Leigh Gavin
by Barrie Dunstan
Australian fund managers may be under more pressure from their big clients to reduce fees following a comprehensive survey by asset consultant Frontier Advisors which was presented to clients at its 20th annual conference last week in Melbourne.
Senior Frontier consultant Leigh Gavin said Australians paid far too much in super fees and in some current cases fees had still been rising as the fund management industry continued to gather the benefits from fees tied to ever-rising funds under management.
Not surprisingly, in the survey, only 6 per cent of fund managers thought they needed to trim fees to be competitive against 42 per cent of Frontier’s consultants. However, later in proceedings, Chris Cuffe delivered a loud wake-up call. The veteran fund manager and now chairman of UniSuper, warned the industry it needed to prepare to halve average management expense ratios (MERs) to a figure like 0.4 per cent.
Gavin said industry-wide costs had risen between 2011 and 2014 – except in the case of retail funds where the switch to My Super products had seen fees fall from 1.61 per cent to 0.78 per cent (and investment returns falter slightly as well). But, reflecting increased regulatory and compliance costs and the move to more costly-to-manage asset classes in portfolios, the average industry fund fees rose from 0.76 per cent to 0.96 per cent, over that period. Fees for corporate and public sector funds also rose, to 0.77 per cent and 0.84 per cent respectively.
Gavin said over the last 20 years, fees had risen in almost a one-for one relationship with the funds under management of the world’s biggest fund managers. Thanks to the ad valorem or flat-fee basis, little of the gains have been shared with investors.
There was little evidence of cost cutting by fund managers, especially on salaries. Fund managers earned high salaries on the premise of rewarding those with skills in short supply – much like the high salaries of world soccer players.
Gavin said Australian super fees, based on an OECD pensions survey, appeared to be higher than in the UK, US and Canada. This reflected differing asset allocations between countries and the contrast between defined benefit and defined contribution schemes.
“But controlling for these factors, the survey shows similar fees,” he said, and no marked drop in costs (except in the system in Chile). As for performance, Frontier found no clear link between performance and fees.
In a review of how investors have handled their fee negotiations with managers, Gavin said unlisted assets couldn’t be excused from a value-for-money assessment and the industry needed to think smarter about what value for money meant in the unlisted sector.
With listed assets, Frontier said clients were only benefiting “somewhat” from benefits of scale while managers were benefitting “absolutely”. And, Gavin asked, “are we negotiating hard enough?” His answer: “occasionally”. For the future, he said, the next five years should concentrate on accruing scale and growth benefits for members.

Investor Strategy News




  • Print Article

    Related
    ‘Bubble thinking’: Howard Marks on market blow-ups

    Higher starting valuations usually lead to lower returns, but the most important part of a bubble is “highly skewed psychology” – and investors remain anchored to sanity.

    David Chaplin | 10th Jan 2025 | More
    ‘Martian real estate’ and bittersweet farewells: ISN’s top 10 stories of 2024

    This year’s top 10 stories included a peek into AustralianSuper’s international equities build out in London, AMP’s move to slash employee benefits, and plenty of hard-hitting analysis of the issues that matter in institutional investment. But the real story is how readers helped shape all of that coverage.

    Lachlan Maddock | 18th Dec 2024 | More
    ‘Nothing will stop me’: Stuart Place rides 15,451 km for son’s rare disease

    Orbis’ Stuart Place is riding from Melbourne to the Moon and Back to fund a treatment for the “monster of a disease” that his youngest son was born with. The investment industry is rallying behind him.

    Lachlan Maddock | 18th Dec 2024 | More
    Popular